SLM:JSESanlam Limited Analysis
Data as of 2026-06-01 - not real-time
ZAC 8,576.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Sanlam Limited is trading at ZAc 8,576, comfortably above its 20‑day SMA of 8,642 but below the 50‑day SMA of 8,753, indicating short‑term pressure. The RSI sits at 45.5, suggesting neutral momentum, while the MACD histogram is positive (+12.4) despite both the MACD line and signal line being in negative territory, hinting at a tentative bullish reversal. Volume is on an increasing trend, supporting the technical upside.
Fundamentally, the company delivers an 8.6% revenue growth rate, a robust operating margin of 55%, and a healthy ROE of 16.9%. Valuation metrics show a trailing PE of 11.4 versus an industry average of 16.6, and a DCF‑derived fair value that implies a 27% upside, classifying the stock as undervalued. The dividend yield of 5.66% with a 59% payout ratio is backed by strong cash flows and a free‑cash‑flow balance sheet, indicating sustainable income. Low beta (≈0.24) and moderate 30‑day volatility (≈19%) point to a defensive risk profile, while the expanding geographic footprint adds diversification benefits.
Fundamentally, the company delivers an 8.6% revenue growth rate, a robust operating margin of 55%, and a healthy ROE of 16.9%. Valuation metrics show a trailing PE of 11.4 versus an industry average of 16.6, and a DCF‑derived fair value that implies a 27% upside, classifying the stock as undervalued. The dividend yield of 5.66% with a 59% payout ratio is backed by strong cash flows and a free‑cash‑flow balance sheet, indicating sustainable income. Low beta (≈0.24) and moderate 30‑day volatility (≈19%) point to a defensive risk profile, while the expanding geographic footprint adds diversification benefits.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- price near support level of ZAc 8,416
- bullish MACD histogram despite negative lines
- increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF‑based upside of ~27% versus current price
- strong operating cash flow and free cash flow generation
- steady earnings growth and attractive dividend yield
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- consistent dividend sustainability with 59% payout ratio
- low beta and defensive volatility profile
- diversified regional exposure across Africa and Asia
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin6.51%
P/E Ratio11.4
ROE16.88%
ROA6.61%
Debt/Equity18.02
P/B Ratio1.8
Op. Cash FlowZAC13.6B
Free Cash FlowZAC524.1B
Industry P/E16.6
Technical Analysis
TrendBearish
RSI45.5
SupportZAC 8,416.00
ResistanceZAC 9,044.00
MA 20ZAC 8,642.10
MA 50ZAC 8,752.90
MA 200ZAC 9,257.87
MACDBullish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair ValueZAC 492,154.31
Target PriceZAC 10,905.00
Upside/Downside27.16%
GradeUndervalued
TypeBlend
Dividend Yield5.66%
Risk Assessment
Beta0.24
Volatility18.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.